← Open Payments lookup

EMILY BALINT: Open Payments

NPI 1982003018 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$466 in 25 payments from 10 companies in 2025. Trend: 2023 $503 · 2024 $671 · 2025 $466

Food & beverage: $466
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc8$163
Neurocrine BioSciences, Inc.4$81
Vanda Pharmaceuticals Inc.3$46
Bausch Health US, LLC2$36
Teva Pharmaceuticals USA, Inc.2$35
Collegium Pharmaceutical, Inc.2$29
Lilly USA, LLC1$24
Alkermes, Inc.1$20
E.R. Squibb & Sons, L.L.C.1$17
Otsuka America Pharmaceutical, Inc.1$15

Products named: INVEGA SUSTENNA, INGREZZA, SPRAVATO, FANAPT, WELLBUTRIN, AUSTEDO XR, Jornay PM, AMYVID.

Industry payments across NJ — which companies pay providers there.